Patients with arterial hypertension and obesity: targeting biomarkers as a personalised therapeutic approach
This literature review focuses on the treatment of patients with arterial hypertension (AH) and obesity, from the point of view of personalised medicine (PM). One of the PM approaches is the use of biochemical markers which reflect normal and pathologic processes in the human body, as well as the pr...
Saved in:
| Main Authors: | T. E. Morozova, E. R. Latyipova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2013-06-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/394 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EVALUATION OF TRANSITION EFFICACY TO ANGIOTENSINE CONVERTING ENZYME INHIBITORS IN PATIENTS WITH INSUFFICIENT BLOOD PRESSURE CONTROL. THE RESULTS FROM REGIONAL PROGRAM “SARA”
by: S. S. Yakushin, et al.
Published: (2017-03-01) -
AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
by: L. L. Kirichenko, et al.
Published: (2014-02-01) -
Obesity and breast cancer: Association of serum adiponectin, leptin, and adiponectin–leptin ratio as risk biomarkers
by: Madhav Danthala, et al.
Published: (2018-01-01) -
Experience of using a fixed-dose combination of perindopril and amlodipine in the clinical practice settings: a real-world opportunity to increase antihypertensive therapy effectiveness
by: O. D. Ostroumova, et al.
Published: (2013-10-01) -
Levels of Leptin, Adiponectin, and Insulin in COVID-19 Patients
by: Sura Zahim HUSSEIN, et al.
Published: (2022-03-01)